Ironwood Pharmaceuticals
IRWD
IRWD
212 hedge funds and large institutions have $2B invested in Ironwood Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 78 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less capital invested
Capital invested by funds: $2.31B → $2B (-$314M)
30% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 43
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
212
Holding in Top 10
2
Calls
$8.35M
Puts
$1.34M
Top Buyers
| 1 | +$22.1M | |
| 2 | +$14.5M | |
| 3 | +$6.64M | |
| 4 |
RA
Royce & Associates
New York
|
+$5.61M |
| 5 |
Renaissance Technologies
New York
|
+$5.48M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$21.1M | |
| 3 | -$16.5M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$11.5M |
| 5 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$8.7M |